MERTK Reduces Blood-Spinal Cord Barrier Permeability Through the RhoA/ROCK1/P-MLC Pathway After Spinal Cord Injury

Medicine, Neurosurgery,
spinal cord injury   MERTK   blood-spinal cord barrier   RhoA/ROCK1/P-MLC pathway   apoptosis   inflammation  

Study on MERTK Reducing Blood-Spinal Cord Barrier Permeability after Spinal Cord Injury via RhoA/ROCK1/p-MLC Pathway Spinal Cord Injury (SCI) is a central nervous system disease caused by trauma, inflammation, tumors, or other pathological reasons, resulting in sensory, motor, and autonomic nervous system dysfunction in patients, imposing a heavy b...

Ferroptosis Inhibitor Improves Outcome After Early and Delayed Treatment in Mild Spinal Cord Injury

Medicine, Medical Laboratory Science, Neurology, Life Sciences, Cell Biology, Biochemistry, Bioengineering, Immunology,
iron toxicity   spinal cord injury   antioxidants   NCOA4   ferritin   lipid peroxidation  

Ferroptosis Inhibitors Improve Early and Delayed Treatment Outcomes of Mild Spinal Cord Injury Academic Background Spinal cord injury (SCI) causes significant secondary damage not only in the acute period but also in the chronic period. These injuries are typically triggered by multiple factors, including oxidative stress, inflammatory response, an...